Contractors / Leidos Biomedical Research Inc
Leidos Biomedical Research Inc
prime recipient of federal awards · reported division of Leidos, Inc. ≈ inferred · UEI HV8BH9BPG8Y9 ✓ from source
$572.1M
obligated · FY2025
1
funding agencies
98%
from Health and Hum…
0%
single-source
1
states
98%
in Maryland
2
industries
≈ computedSingle-source: 0% of this recipient’s $559.6M in federal contracts was awarded without competition (FPDS extent-competed codes); the rest was competed or unclassified. A high share often reflects sole-source or specialized work, not wrongdoing.
Obligations by year
≈ computed$1.2B
FY23
$869.3M
FY24
$572.1M
FY25
▼ 52%
since FY23
Where this money comes from
✓ from sourceFUNDING AGENCIES
LEIDOS BIOMEDICAL RESEAR
HHS
$0.6B
Leidos Biomedical Research Inc
$0.6B
FY2025 obligated
Biggest awards (total value)
awarded 2008$4.8B
awarded 2020$1.8B
awarded 2019$432.4M
awarded 2024$398.9M
awarded 2025$327.1M
awarded 2020$291.2M
awarded 2020$233.6M
Total value over each award’s life, for awards active in FY2025: a decades-long contract can exceed one year’s obligations above.
What it does (NAICS / PSC)
Where the work lands
Maryland✓ from source$559.6M
Competitors
Lockheed Martin Corporation≈ computed$5.9B
Fluor Marine Propulsion, LLC≈ computed$3.6B
California Institute of Technology≈ computed$2.4B
Fermi Forward Discovery Group, LLC≈ computed$1.7B
Northrop Grumman Systems Corporation≈ computed$1.5B
The Aerospace Corporation≈ computed$1.4B
Booz Allen Hamilton Inc≈ computed$1B
computed from shared NAICS, not a stated rivalry.
Corporate family
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.